Predictive Biomarkers to Immune Checkpoint Inhibitors in Lung Cancer

3,470
Total downloads
20k
Total views and downloads

Participate in this topic

Articles

SYSTEMATIC REVIEW

Published on 03 Dec 2025

Synergistic efficacy and safety of PD-1/PD-L1 inhibitors combined with nab-paclitaxel and platinum chemotherapy in NSCLC: A systematic review and meta-analysis of randomized controlled trials

Yijing Shen

doi 10.3389/fonc.2025.1649777

140 views

SYSTEMATIC REVIEW

Published on 10 Nov 2025

The impact of comorbid COPD on survival outcomes in lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Lin Chen
Dandan Song
Shufu Hou
Aiju Liu
Jing Gao
Lei Wang

doi 10.3389/fimmu.2025.1627557

661 views

ORIGINAL RESEARCH

Published on 21 Oct 2025

Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitors

David Gandara
Miranda Gogishvili
Ahmet Sezer
Tamta Makharadze
Mahmut Gümüş
Cong Zhu
Eric Yan
Giuseppe Gullo
Petra Rietschel
Ruben G. W. Quek

doi 10.3389/fimmu.2025.1640595

1,880 views

SYSTEMATIC REVIEW

Published on 30 Sep 2025

Prognostic value of baseline LIPI, LDH and dNLR in ES-SCLC patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

Chenyi Zhou
Quanman Hu
Xiaoru Song
Xiyin Wang
Ran Kong
Fei Zhao
Boying Wu
Shuaiyin Chen
Bin Jia

doi 10.3389/fimmu.2025.1640066

2,385 views

CASE REPORT

Published on 29 Sep 2025

Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker

Xiayu Wang
Yiwei Zhou
Qijiao Li
Jun Wang
Yu Qian
Bing Yang

doi 10.3389/fimmu.2025.1618118

995 views

REVIEW

Published on 15 Aug 2025

Immune checkpoints in immune response to glioma: two sides of the same coin

Oxana Musatova
Vikas Kumar
Konstantin Vinogradov
Yury Rubtsov

doi 10.3389/fimmu.2025.1639521

2,481 views
1 citation

CASE REPORT

Published on 11 Aug 2025

Case Report: When dual immune checkpoint blockade strikes back: cadonilimab-induced hypersensitivity in solid tumors — a case series and review

Ping Song
Yuqi Jin
Linglin Fu
Fengming Yang
Yinuo Tan

doi 10.3389/fimmu.2025.1643279

1,432 views

ORIGINAL RESEARCH

Published on 11 Aug 2025

UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma

Haofeng Yin
Yibo Xue
Chen Wang
Yanqin Wu
Yuchen Guo
Chunzhen Li
Yunyan Zhang
Shulei Yin
Tiejun Zhao

doi 10.3389/fimmu.2025.1636503

2,244 views

REVIEW

Published on 10 Jun 2025

Multiple signaling pathways in the frontiers of lung cancer progression

Hao Liu
Dujuan Zhou
Yangjing Ou
Shuanghua Chen
Yunzhu Long
Ting Yuan
Yukun Li
Yingzheng Tan

doi 10.3389/fimmu.2025.1593793

3,633 views
3 citations

Share on

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Other participating journals

Frontiers in Oncology
- Cancer Immunity and Immunotherapy
- 3.3 impact factor
- 6.9 citescore

Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.

Impact

20kTopic views
15kArticle views
3,470Article downloads

View impact

Articles

Synergistic efficacy and safety of PD-1/PD-L1 inhibitors combined with nab-paclitaxel and platinum chemotherapy in NSCLC: A systematic review and meta-analysis of randomized controlled trials

The impact of comorbid COPD on survival outcomes in lung cancer patients treated with immune checkpoint inhibitors: a meta-analysis

Prognostic value of patient-reported outcomes for survival in patients with advanced lung cancer receiving immune checkpoint inhibitors

Prognostic value of baseline LIPI, LDH and dNLR in ES-SCLC patients receiving immune checkpoint inhibitors: a systematic review and meta-analysis

Case Report: Prognostic evaluation of immunotherapy in two patients with SMARCA4-UT using TCR as a new marker

Immune checkpoints in immune response to glioma: two sides of the same coin

Case Report: When dual immune checkpoint blockade strikes back: cadonilimab-induced hypersensitivity in solid tumors — a case series and review

UBE2N as a novel prognostic and therapeutic biomarker of lung adenocarcinoma

Multiple signaling pathways in the frontiers of lung cancer progression

Frontiers in Immunology

Cancer Immunity and Immunotherapy

Other participating journals

Frontiers in Oncology

Cancer Immunity and Immunotherapy